Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathwaySheng Han, Anhua Wu|British Journal of Cancer|2014Cited by 108
<p>IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma</p>Chen Zhu, Anhua Wu|OncoTargets and Therapy|2020Cited by 53
Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signallingSheng Han, Anhua Wu|British Journal of Cancer|2017Cited by 30
<p>Secretory Pathway Kinase <em>FAM20C</em>, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma</p>Shaonan Du, Anhua Wu|OncoTargets and Therapy|2020Cited by 16
Molecular profiling identifies distinct subtypes across TP53 mutant tumorsXin Chen, Anhua Wu|JCI Insight|2022Cited by 9